MIRA INFORM REPORT

 

 

Report Date :

11.03.2013

 

IDENTIFICATION DETAILS

 

Name :

BIOFARMA ILAC SANAYI VE TICARET A.S.

 

 

Formerly Known as:

Biofarma Ilac Sanayi Ltd. Sti.

 

 

Registered Office :

Sancaktepe Akpinar Mah. Osmangazi Cad. No:156  Istanbul

 

 

Country :

Turkey

 

 

Date of Incorporation :

07.01.1953

 

 

Com. Reg. No.:

47638

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture and trade of medicine. 

 

 

No. of Employees :

600

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate  

 

 

Payment Behaviour :

Unknown 

 

 

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Turkey

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

Turkey - ECONOMIC OVERVIEW

 

Turkey's largely free-market economy is increasingly driven by its industry and service sectors, although its traditional agriculture sector still accounts for about 25% of employment. An aggressive privatization program has reduced state involvement in basic industry, banking, transport, and communication, and an emerging cadre of middle-class entrepreneurs is adding dynamism to the economy and expanding production beyond the traditional textiles and clothing sectors. The automotive, construction, and electronics industries, are rising in importance and have surpassed textiles within Turkey's export mix. Oil began to flow through the Baku-Tbilisi-Ceyhan pipeline in May 2006, marking a major milestone that will bring up to 1 million barrels per day from the Caspian to market. Several gas pipelines projects also are moving forward to help transport Central Asian gas to Europe through Turkey, which over the long term will help address Turkey's dependence on imported oil and gas to meet 97% of its energy needs. After Turkey experienced a severe financial crisis in 2001, Ankara adopted financial and fiscal reforms as part of an IMF program. The reforms strengthened the country's economic fundamentals and ushered in an era of strong growth - averaging more than 6% annually until 2008. Global economic conditions and tighter fiscal policy caused GDP to contract in 2009, but Turkey's well-regulated financial markets and banking system helped the country weather the global financial crisis and GDP rebounded strongly to 8.2% in 2010, as exports returned to normal levels following the recession. Turkey's public sector debt to GDP ratio has fallen to roughly 40%. Continued strong growth has pushed inflation to the 8% level, however, and worsened an already high current account deficit. Turkey remains dependent on often volatile, short-term investment to finance its large trade deficit. The stock value of FDI stood at $99 billion at year-end 2011. Inflows have slowed considerably in light of continuing economic turmoil in Europe, the source of much of Turkey's FDI. Further economic and judicial reforms and prospective EU membership are expected to boost Turkey's attractiveness to foreign investors. However, Turkey's relatively high current account deficit, uncertainty related to monetary policy-making, and political turmoil within Turkey's neighborhood leave the economy vulnerable to destabilizing shifts in investor confidence.

 

Source : CIA

 

 


 

 

 

NOTES

:

Address at your inquiry was changed by the authority/municipality.

 

 

COMPANY IDENTIFICATION

 

 

NAME

:

BIOFARMA ILAC SANAYI VE TICARET A.S.

HEAD OFFICE ADDRESS

:

Sancaktepe Akpinar Mah. Osmangazi Cad. No:156  Istanbul / Turkey

REMARKS ON HEAD OFFICE ADDRESS

:

The address was changed from “Fatih Cad. No:17” to “Osmangazi Cad. No:156” by the Municipality.

PHONE NUMBER

:

90-216-398 10 63

 

FAX NUMBER

:

90-216-398 10 20

90-216-398 78 35

 

WEB-ADDRESS

:

www.biofarma.com.tr

 

 

LEGAL STATUS AND HISTORY

 

 

TAX OFFICE

:

Buyuk Mukellefler

TAX NO

:

1760041077

REGISTRATION NUMBER

:

47638

REGISTERED OFFICE

:

Istanbul Chamber of Commerce

DATE ESTABLISHED

:

07.01.1953

LEGAL FORM

:

Joint Stock Company

TYPE OF COMPANY

:

Private

REGISTERED CAPITAL

:

TL   115.987.750

 

HISTORY

:

Previous Legal Type

:

Limited Company

Changed On

:

31.07.1997 (Commercial Gazette Date /Number 06.08.1997/ 4348)

Previous Name

:

Biofarma Ilac Sanayi Ltd. Sti.

Changed On

:

31.07.1997 (Commercial Gazette Date /Number 06.08.1997/ 4348)

Previous Registered Capital

:

TL 25.000.000

Changed On

:

19.07.2005 (Commercial Gazette Date /Number 22.07.2005/ 6352)

Previous Registered Capital

:

TL 41.000.000

Changed On

:

18.05.2007 (Commercial Gazette Date /Number 24.05.2007/ 6815)

Previous Registered Capital

:

TL 82.000.000

Changed On

:

04.05.2012 (Commercial Gazette Date /Number 10.05.2012/ 8065)

Merger

:

The firm took over and merged with “Biofarm Ilac Sanayi ve Ticaret A.S".

Changed On

:

18.05.2007 (Commercial Gazette Date /Number 24.05.2007/ 6815)

 

 

OWNERSHIP / MANAGEMENT

 

 

SHAREHOLDERS

:

Isanne S.a.r.l.

100 %

 

 

REMARKS ON SHAREHOLDERS

:

We are informed that “Isanne S.a.r.l.” is a foreign company located at Luxembourg.

 

BOARD OF DIRECTORS

:

Yuval Kadim

Chairman

Colin Douglas Clark

Vice-Chairman

Sunil Kumar Nair

Member

Mihalis Madianos

Member

 

 

OPERATIONS

 

 

BUSINESS ACTIVITIES

:

Manufacture and trade of medicine. 

 

NACE CODE

:

DF.24.42

 

SECTOR

:

Chemicals

 

TRADEMARKS OWNED

:

Allarin

Canolen

Fluzole

Fulsac

Gelocaps

Katarin

Mukoral

Relaxol

Ressital

Synergon

Uterjin

 

NUMBER OF EMPLOYEES

:

600

 

NET SALES

:

59.632 TL Thousand

(2003)  

72.445 TL Thousand

(2004) 

94.628 TL Thousand

(2005) 

114.581 TL Thousand

(2006) 

122.567 TL Thousand

(2007) 

173.811 TL Thousand

(2008) 

135.405 TL Thousand

(2009) 

160.205 TL Thousand

(2010) 

 

 

REMARKS ON NET SALES

:

In Turkey, there is no public registry on companies’ financial and detailed general data. So, to collect a firm’s data, an information agency has to contact the company and get its authorization. 

 

However the company strictly declines to give us an authorization to gather its fresh financial data. As the firm’s shares are not open to public it is not obliged to announce its data.

 

IMPORT COUNTRIES

:

Netherlands

China

India

Germany

Switzerland

Italy

 

MERCHANDISE IMPORTED

:

Raw materials

 

EXPORT VALUE

:

154 USD

(2003)

841 USD

(2004)

237 USD

(2005)

2.525.436 TL

(2006)

3.280.000 USD

(2007)

4.097.000 USD

(2008)

3.198.000 USD

(2009)

6.388 USD Thousand

(2010)

 

 

EXPORT COUNTRIES

:

Croatia

Serbia

Spain

Switzerland

India

Iraq

Algeria

Bosnia and Herzegovina

Turkmenistan

Kazakhstan

Czech Republic

Portugal

Greece

 

MERCHANDISE  EXPORTED

:

Medicine

 

HEAD OFFICE ADDRESS

:

Sancaktepe Akpinar Mah. Osmangazi Cad. No:156  Istanbul / Turkey

 

 

 

BRANCHES

:

Regional Directorate  :  Ornektepe Mah. Ornektepe  Cad. Dolunay Is Merkezi  No:165 D:5 Sutluce Istanbul/Turkey

 

Regional Directorate  :  Kahramanciftlik Cad. G / 58 Sok. No:2 Kat : 1/2    Icerenkoy Kadikoy Istanbul/Turkey

 

Regional Directorate  :  Akpinar Mah. Denizevler Kavakli Cad. No:29 Osmangazi Bursa/Turkey

 

Regional Directorate  :  Suleyman  Demirel Bulvari Huzurevleri Mah.  162 Sok. Ferhat Ozkan Apt.  Asma Kat Seyhan Adana/Turkey

 

Regional Directorate  :  Yatik Musluk  Mh. Aslan Agzi  Sk.  No:3/4 Gulveren Ankara/Turkey

 

Regional Directorate  :  2 Nolu Besirli Mah. Esref Bitlis Cad. Osa Apt. No:2  D:3 Trabzon/Turkey

 

Regional Directorate  :  Uluc Mah.  1151 Sokak Cetin Is Merkezi No:2 D:6 Konyaalti Antalya/Turkey

 

Regional Directorate  :  Yeni Kale Mah.Zafer Sok. No.7 Narlidere Izmir/Turkey

 

Regional Directorate  :  Guzelyali Mah. 32 Sok. No:3 Kat:3 Atakent Samsun/Turkey

 

Regional Directorate  :  Tekel Cad. Hayat 2 Sitesi A-Blok K:1 No:1-2 Diclekent Diyarbakir/Turkey

 

Regional Directorate  :  Cevre Yolu Uzeri Adliye Kavsagi Matim Is  Merkezi A Blok D:36  Kat : 7  P.K. 44200 Malatya/Turkey

 

Head Office/Factory  :  Sancaktepe Akpinar Mah. Osmangazi Cad. No:156 Istanbul/Turkey  (15.000 sqm)

 

INVESTMENTS

:

Investments are going on.

 

 

FINANCE

 

 

MAIN DEALING BANKS

:

Akbank Kozyatagi Kurumsal Branch

Garanti Bankasi Sultanbeyli Branch

HSBC Bank Kozyatagi Branch

T.Is Bankasi Kartal Ticari Branch

Yapi ve Kredi Bankasi Kartal Branch

 

PAYMENT BEHAVIOUR

:

No payment delays have come to our knowledge.

 

 

 

COMMENT ON FINANCIAL POSITION

 

 

General Financial Position

General financial position is undetermined the firm declines to give us an authorization to gather its financial data. As the shares of the firm are not open to public, it is not obliged to announce its data.

 

 

 

Incr. in producers’ price index

 

Average USD/TL

Average EUR/TL

Average GBP/ TL

 ( 2006 )

11,58 %

1,4309

1,7987

2,6377

 ( 2007 )

5,94 %

1,3075

1,7901

2,6133

 ( 2008 )

8,11 %

1,2858

1,8876

2,3708

 ( 2009 )

5,93 %

1,5460

2,1529

2,4094

 ( 2010 )

8,87 %

1,5128

2,0096

2,3410

 ( 01.01-28.02.2013)

-0,31 %

1,7828

2,3690

2,8041

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.40

UK Pound

1

Rs.81.57

Euro

1

Rs.71.24

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.